Vaccines

Covid 19 latest news: New covid variant JN.1, a variant of interest, has been classified by the World Health Organization. Vaccines may not completely block JN.1 infections, but they can reduce the likelihood of severe illness and hospitalisation

COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, says ICMR study.

FDA authorizes updated COVID-19 vaccines from Pfizer/BioNTech and Moderna targeting the Omicron variant; Novavax is still under review.

COVID-19 cases have surged, prompting discussions on the need for mask-wearing amid concerns over new variants and the upcoming respiratory virus season. Experts emphasise the importance of masks, especially in high-risk scenarios.

India sees jump in daily corona cases today. On Thursday too, the country saw a significant jump in Covid cases

Click here to download the Mint App https://livemint.onelink.me/MrDS/p0kx3pdg

The video highlights the fact that India is quickly emerging as a global biotech powerhouse, with a growing number of companies and startups making significant contributions to the global biotechnology industry. India's biotech sector is diverse, with companies involved in various fields, such as biopharmaceuticals, diagnostics, genomics, and agriculture.

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launch Bharat Biotech’s nasal Covid-19 Made-in-India vaccine iNCOVACC

The authorities have also informed that Covid deaths had reached a daily peak of more than 4,000 in January this year, around the first week.